AU3134799A - Nevron growth inhibitory molecules or derivatives thereof used to immunize mammals thereby promoting axon regeneration - Google Patents

Nevron growth inhibitory molecules or derivatives thereof used to immunize mammals thereby promoting axon regeneration

Info

Publication number
AU3134799A
AU3134799A AU31347/99A AU3134799A AU3134799A AU 3134799 A AU3134799 A AU 3134799A AU 31347/99 A AU31347/99 A AU 31347/99A AU 3134799 A AU3134799 A AU 3134799A AU 3134799 A AU3134799 A AU 3134799A
Authority
AU
Australia
Prior art keywords
nevron
derivatives
growth inhibitory
inhibitory molecules
axon regeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31347/99A
Other languages
English (en)
Inventor
Peter Erich Braun
Samuel David
Lisa Joan Mckerracher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3134799A publication Critical patent/AU3134799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
AU31347/99A 1998-04-16 1999-04-16 Nevron growth inhibitory molecules or derivatives thereof used to immunize mammals thereby promoting axon regeneration Abandoned AU3134799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2234921 1998-04-16
CA2234921 1998-04-16
PCT/CA1999/000304 WO1999053945A1 (fr) 1998-04-16 1999-04-16 Molecules inhibant la croissance neuronale ou leurs derives utilises pour immuniser des mammiferes et ainsi favoriser la regeneration de l'axone

Publications (1)

Publication Number Publication Date
AU3134799A true AU3134799A (en) 1999-11-08

Family

ID=4162334

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31347/99A Abandoned AU3134799A (en) 1998-04-16 1999-04-16 Nevron growth inhibitory molecules or derivatives thereof used to immunize mammals thereby promoting axon regeneration

Country Status (2)

Country Link
AU (1) AU3134799A (fr)
WO (1) WO1999053945A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020072493A1 (en) 1998-05-19 2002-06-13 Yeda Research And Development Co. Ltd. Activated T cells, nervous system-specific antigens and their uses
JP2003532618A (ja) * 1998-05-19 2003-11-05 イエダ リサーチ アンド デベロプメント カンパニイ リミテッド 細胞、神経系−特異的抗原およびそれらの用途
DE60142023D1 (de) 2000-01-12 2010-06-17 Univ Yale Nogo rezeptor-vermittelte blockade des axonalen wachstums
AUPQ614200A0 (en) * 2000-03-10 2000-03-30 Department Of Human Physiology, Flinders University School Of Medicine Method for treating chronic spinal cord injury
GB0103174D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Plc Novel method of treatment
TWI323265B (en) 2002-08-06 2010-04-11 Glaxo Group Ltd Antibodies
GB0306309D0 (en) * 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
EP2230305A1 (fr) 2005-07-21 2010-09-22 Alnylam Pharmaceuticals Inc. Modulation de l'arni du gène rho-a et utilisations de celle-ci

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB191326535A (en) * 1913-11-19 1914-04-23 Charles Jules Henri Nicolle Improvements in and relating to Vaccines, Cultures and the like and the Preparation thereof.
GB9403250D0 (en) * 1994-02-21 1994-04-13 Univ Mcgill Therapeutic use of myelin-associated glycoprotein (mag)
AU6858596A (en) * 1995-08-25 1997-03-19 Johns Hopkins University School Of Medicine, The Compounds for stimulating nerve growth
CA2190418A1 (fr) * 1996-11-15 1998-05-15 Zhi-Cheng Xiao Systeme regulateur pour la croissance des neurones et des tumeurs neuronales; anticorps utilises a cette fin et applications

Also Published As

Publication number Publication date
WO1999053945A8 (fr) 2000-03-02
WO1999053945A1 (fr) 1999-10-28

Similar Documents

Publication Publication Date Title
AU5711196A (en) Apoptosis inducing molecule i
AU7002596A (en) System for production of hydrocarbons
AU3091899A (en) Obligated investment system
AU7631496A (en) Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
AU5490199A (en) Process for the purification of 1,3-propanediol
AU6726496A (en) Two-pulse, lateral tissue illuminator
AU4136701A (en) Security system linked to the internet
AU8800598A (en) B7-binding molecules for treating immune diseases
AU695351B2 (en) Adjustable cam track
AU5531599A (en) Novel cdk inhibitors having flavone structure
AU4208897A (en) Oligocistronic expression system for the production of heteromeric proteins
AU3134799A (en) Nevron growth inhibitory molecules or derivatives thereof used to immunize mammals thereby promoting axon regeneration
DK1021444T3 (da) 5H-Pyrrolo-[2,1-c][1,4]benzodiazepin-3-carboxamidderivat
AU5570899A (en) Purified human papillomavirus
AU4041997A (en) Dna purification procedure
AU1361099A (en) Molecular compounds having complementary surfaces to targets and methods for thesynthesis and use thereof
AU1466401A (en) Human transferase molecules
AU2113899A (en) Human protein kinase molecules
AU2587399A (en) Human transport-associated molecules
AU689887B2 (en) Oligonucleotides to inhibit the expression of isoprenyl protein transferases
AU2250997A (en) Purification of 1,1,1,3,3-pentafluoropropane
AU5065698A (en) Improvements to gas-masks
AU4729199A (en) Monocyte locomotion inhibitory factor
AU4747597A (en) CO2 treatment to remove calcium from crude
AU1331600A (en) Growth factor related molecules

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase